MERCK Kommanditgesellschaft auf Aktien logo

MERCK Kommanditgesellschaft auf Aktien (MRK)

Market Open
1 Apr, 13:19
128. 15
+2
+1.59%
- Market Cap
23.04 P/E Ratio
2.39% Div Yield
0 Volume
0 Eps
126.15
Previous Close
Day Range
127 128.2
Year Range
125.6 176.5
Earnings results expected in 43 days

Summary

MRK trading today higher at €128.15, an increase of 1.59% from yesterday's close, completing a monthly increase of 0.71% or €0.9. Over the past 12 months, MRK stock lost -8.46%.
MRK pays dividends to its shareholders, with the most recent payment made on May 02, 2024. The next announced payment will be in In 4 weeks on Apr 30, 2025 for a total of €2.2.
The last earnings report, released on Mar 06, 2025, missed the consensus estimates by -0.12%. On average, the company has fell short of earnings expectations by -0.03%, based on the last three reports. The next scheduled earnings report is due on May 15, 2025.
MERCK Kommanditgesellschaft auf Aktien has completed 1 stock splits, with the recent split occurring on Jun 30, 2014.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on XWBO (EUR).
Want to track MRK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

MRK Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

MERCK Kommanditgesellschaft auf Aktien Dividends

MERCK Kommanditgesellschaft auf Aktien logo
MRK In 3 weeks
Estimated
Interim
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK In 3 weeks
Announced
Interim
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 11 months ago
Paid
Final
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 2 May 2023
Paid
Final
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 25 Apr 2022
Paid
Final
€1.85 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 26 Apr 2021
Paid
Final
€1.4 Per Share

MERCK Kommanditgesellschaft auf Aktien Earnings

15 May 2025 (43 Days) Date
-
Cons. EPS
-
EPS
6 Mar 2025 Date
2.19
Cons. EPS
2.07
EPS
14 Nov 2024 Date
2.27
Cons. EPS
2.3
EPS
1 Aug 2024 Date
-
Cons. EPS
-
EPS
15 May 2024 Date
1.84
Cons. EPS
-
EPS
MERCK Kommanditgesellschaft auf Aktien logo
MRK In 3 weeks
Estimated
Interim
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK In 3 weeks
Announced
Interim
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 11 months ago
Paid
Final
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 2 May 2023
Paid
Final
€2.2 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 25 Apr 2022
Paid
Final
€1.85 Per Share
MERCK Kommanditgesellschaft auf Aktien logo
MRK 26 Apr 2021
Paid
Final
€1.4 Per Share
15 May 2025 (43 Days) Date
-
Cons. EPS
-
EPS
6 Mar 2025 Date
2.19
Cons. EPS
2.07
EPS
14 Nov 2024 Date
2.27
Cons. EPS
2.3
EPS
1 Aug 2024 Date
-
Cons. EPS
-
EPS
15 May 2024 Date
1.84
Cons. EPS
-
EPS

MERCK Kommanditgesellschaft auf Aktien (MRK) FAQ

What is the stock price today?

The current price is €128.15.

On which exchange is it traded?

MERCK Kommanditgesellschaft auf Aktien is listed on XWBO.

What is its stock symbol?

The ticker symbol is MRK.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on May 15, 2025.

Has MERCK Kommanditgesellschaft auf Aktien ever had a stock split?

MERCK Kommanditgesellschaft auf Aktien had 1 splits and the recent split was on Jun 30, 2014.

MERCK Kommanditgesellschaft auf Aktien Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Ms. Belen Garijo Lopez M.D. CEO
XFRA Exchange
DE0006599905 ISIN
US Country
62,908 Employees
23 Aug 1970 Last Dividend
- Last Split
- IPO Date

Overview

Merck KGaA is a prominent science and technology entity based in Germany, spanning its operations through diversified sectors such as Life Science, Healthcare, and Electronics. As of its inception in 1668, the company has distinguished itself by contributing significantly to academic, biotech, pharmaceutical, and industrial fields with its comprehensive range of tools, chemicals, and technology solutions. It is an influential subsidiary of E. Merck KGaA, with its headquarters located in Darmstadt, Germany. Through its international collaborations and in-licensing agreements with companies like Debiopharm International SA, Jiangsu Hengrui Pharmaceuticals Co. Ltd., and Abbisko Therapeutics Co. Ltd., Merck KGaA continues to bolster its position in developing innovative treatments in areas such as oncology, neurology, and various other critical disease sectors.

Products and Services

  • Life Science Solutions

    Merck KGaA offers an extensive suite of products tailored for the Life Science industry, catering to academic labs, biotech, and pharmaceutical manufacturers. This includes process development expertise, technologies for continuous bioprocessing, testing kits, chemical reagents, and services designed for air, water, and soil analysis. They also provide tools that assess the nutritional value and identify quality inconsistencies, aiming to support the entire biopharmaceutical manufacturing value chain.

  • Healthcare and Biopharmaceuticals

    The company plays a pivotal role in the healthcare sector by discovering, developing, manufacturing, and marketing a broad portfolio of prescription drugs and biopharmaceutical products. These offerings are directed toward treating conditions in oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. Moreover, it includes general medicines along with injection devices and disease monitoring software, stressing the importance of comprehensive patient care.

  • Electronics Segment

    Merck KGaA extends its expertise to the semiconductor and display industries by supplying critical materials and solutions for surface design. This encompasses delivery systems and services, as well as innovative surface solutions like cosmetics, effect pigments, and functional solutions. Their contributions are vital for the development and manufacturing processes in the electronics sector, showcasing their versatility and capacity to meet diverse industry needs.

  • In-licensing Agreements and Collaborations

    The company has established several significant in-licensing agreements and collaborations aimed at the development and commercialization of drug candidates. This includes partnerships for targeting conditions like head and neck cancer, metastatic colorectal cancer, and tenosynovial giant cell tumor. Such endeavors signify Merck KGaA's commitment to addressing global health challenges through innovation and strategic partnerships.

Contact Information

Address: Frankfurter Strasse 250, Darmstadt, Germany, 64293
Phone: 49 6151 72 0